×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ALBERT DAVID LTD. | 926.03 | 79.38 | 705.66 | 13.91 | 460.0 | 73.1 |
| OXYGENTA PHARMACEUTICAL LIMITE | NA | NA | NA | NA | 456 | |
| BROOKS LABORATORIES LTD. | 257.29 | 26.51 | 255.12 | 0.9 | 435 | 214.0 |
Albert David Ltd.,, with Security Code 524075, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 81.4 | 91.9 | 93.2 | 88.3 | 89.1 | 89.4 | 98.4 | 83.1 | 74.9 | 70.6 |
| Expenses | 71.8 | 79.0 | 77.2 | 79.9 | 79.5 | 88.5 | 92.2 | 82.4 | 79.6 | 81.2 |
| Operating Profit | 9.6 | 13.0 | 16.0 | 8.4 | 9.6 | 0.9 | 6.2 | 0.7 | -4.7 | -10.7 |
| OPM % | 11.78% | 14.13% | 17.14% | 9.46% | 10.75% | 0.98% | 6.32% | 0.81% | -6.22% | -15.1% |
| Other Income | 0.0 | 18.1 | 12.1 | 16.9 | 10.4 | 23.1 | 20.6 | -9.0 | -5.1 | 22.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.6 |
| Depreciation | 2.3 | 1.9 | 1.5 | 1.7 | 1.8 | 1.8 | 1.7 | 1.7 | 1.8 | 2.4 |
| Profit before tax | 7.2 | 29.2 | 26.5 | 23.4 | 18.1 | 22.1 | 25.1 | -10.2 | -11.7 | 8.4 |
| Tax % | -48.1% | -19.5% | -23.5% | -20.1% | 28.7% | 14.6% | 28.1% | -7.6% | 0% | 5.9% |
| Net Profit | 3.7 | 23.5 | 20.3 | 18.7 | 12.9 | 18.8 | 18.1 | -9.4 | -10.3 | 7.9 |
| EPS in Rs | 6.54 | 41.16 | 35.57 | 32.8 | 22.63 | 33.02 | 31.67 | -16.45 | 0 | 13.91 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | -20% |
| TTM: | -77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 15% |
| 1 Year: | -29% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|